UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 481

Sortiert nach

Cancer and Venous Thromboembolic Disease: A Review

The oncologist (Dayton, Ohio), 2017-02, Vol.22 (2), p.199-207

2017

Link zum Volltext

Verfügbarkeit prüfen

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States

Cancer, 2013-02, Vol.119 (3), p.648-655

2013

Link zum Volltext

Verfügbarkeit prüfen

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

Journal of clinical oncology, 2009-10, Vol.27 (29), p.4839-4847

2009

Link zum Volltext

Verfügbarkeit prüfen

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

The lancet oncology, 2016-10, Vol.17 (10), p.e452-e466

2016

Link zum Volltext

Verfügbarkeit prüfen

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology

Journal of clinical oncology, 2018-08, Vol.36 (22), p.2326-2347

2018

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms and biomarkers of cancer-associated thrombosis

Translational research : the journal of laboratory and clinical medicine, 2020-11, Vol.225, p.33-53

2020

Link zum Volltext

Verfügbarkeit prüfen

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2019-10, Vol.17 (10), p.1772-1778

2019

Link zum Volltext

Verfügbarkeit prüfen

Time to initial cancer treatment in the United States and association with survival over time: An observational study

PloS one, 2019-03, Vol.14 (3), p.e0213209

2019

Link zum Volltext

Verfügbarkeit prüfen

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update

Journal of clinical oncology, 2019-08, Vol.37 (23), p.2082-2088

2019

Link zum Volltext

Verfügbarkeit prüfen

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion

Journal of clinical oncology, 2019-01, Vol.37 (2), p.153-164

2019

Link zum Volltext

Verfügbarkeit prüfen

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-07, Vol.34 (21), p.2541-2556

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a predictive model for chemotherapy-associated thrombosis

Blood, 2008-05, Vol.111 (10), p.4902-4907

2008

Link zum Volltext

Verfügbarkeit prüfen

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-06, Vol.31 (17), p.2189-2204

2013

Link zum Volltext

Verfügbarkeit prüfen

Guidance for the prevention and treatment of cancer-associated venous thromboembolism

Journal of thrombosis and thrombolysis, 2016, Vol.41 (1), p.81-91

2016

Link zum Volltext

Verfügbarkeit prüfen

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-08, Vol.34 (22), p.2654-2668

2016

Link zum Volltext

Verfügbarkeit prüfen

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients

Cancer, 2007-11, Vol.110 (10), p.2339-2346

2007

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Journal of clinical oncology, 2016-08, Vol.34 (23), p.2784-2796

2016

Link zum Volltext

Verfügbarkeit prüfen

Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer

The American journal of medicine, 2014, Vol.127 (1), p.82-86.e1

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?

Thrombosis research, 2016-09, Vol.145, p.51-53

2016

Link zum Volltext

Verfügbarkeit prüfen

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Journal for immunotherapy of cancer, 2021-01, Vol.9 (1), p.e001719

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombotic Complications Associated with Immune Checkpoint Inhibitors

Cancers, 2021-09, Vol.13 (18), p.4606

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3605-3610

2010

Link zum Volltext

Verfügbarkeit prüfen

A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality

The oncologist (Dayton, Ohio), 2016-07, Vol.21 (7), p.861-867

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

The oncologist (Dayton, Ohio), 2018-02, Vol.23 (2), p.247-255

2018

Link zum Volltext

Verfügbarkeit prüfen

Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease

PloS one, 2023-04, Vol.18 (4), p.e0283021-e0283021

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 481

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(462)
Mit Volltextzugriff
(444)

Publikationsform

Sprache

Englisch
(481)
Japanisch
(40)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Cancer and Venous Thromboembolic Disease: A Review

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States

Assessing Risk of Venous Thromboembolism in the Patient With Cancer

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer

Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology

Mechanisms and biomarkers of cancer-associated thrombosis

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

Time to initial cancer treatment in the United States and association with survival over time: An observational study

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Development and validation of a predictive model for chemotherapy-associated thrombosis

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Guidance for the prevention and treatment of cancer-associated venous thromboembolism

Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer

Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?

Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival

Thrombotic Complications Associated with Immune Checkpoint Inhibitors

Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality

Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)

Microbiomic profiles of bile in patients with benign and malignant pancreaticobiliary disease

Suchergebnisse filtern